The Effect of Virtual Reality and Buzzy Application on Pain, Fear and Anxiety During Prick Test in Children
Launched by KTO KARATAY UNIVERSITY · Jun 3, 2024
Trial Information
Current as of February 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Allergy is a hypersensitivity reaction to a triggering agent. Tests used in allergy are divided into two: in vivo and in vitro. Among the in vivo tests routinely used, epidermal, intradermal and patch tests are used, and the most commonly used is the skin prick test. In order to prevent the negative effects of pain, it is important to be informed about the appropriate approach to children, newborns and babies, and effective pain management, according to their cognitive development levels. Pain management in children should be done appropriately with accurate assessment tools. This will incr...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The child must be between the ages of 7-10
- • It will be the first time that a prick test will be applied.
- • The child can speak and understand Turkish comfortably
- • He and his family agree to participate in the study.
- • Not having used analgesic medication at least six hours ago
- Exclusion Criteria:
- • The child has any diagnosed psychiatric disorder
- • Having visual, auditory or speech disorders
- • Having a chronic disease other than allergy
Trial Officials
Emine Geçkil
Principal Investigator
Necmettin Erbakan Üniversitesi Hemşirelik Fakültesi
About Kto Karatay University
KTO Karatay University, a leading institution in Turkey dedicated to advancing healthcare education and research, actively sponsors clinical trials to enhance medical knowledge and improve patient outcomes. With a strong emphasis on innovation and ethical practices, the university collaborates with healthcare professionals and researchers to conduct rigorous clinical studies. Through these trials, KTO Karatay University aims to contribute valuable insights into various medical fields, fostering the development of effective therapies and treatment protocols that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0